Skip to content
TriangleGet started
← Back to this collection

PUBLICATIONS · 24859363

Carfilzomib, rituximab, and dexamethasone (CaRD) treatment offers a neuropathy-sparing approach for treating Waldenström's macroglobulinemia.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
Blood
Publication date
2014 Jul 24
First author
Treon SP

Publication notices

absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    Blood. 2014 Jul 24;124(4):468-9. doi: 10.1182/blood-2014-06-578625.
    note
    Source null
    related pmid
    25061164
    relationship
    Comment in

Authors and identifiers

  1. name
    Treon SP
    type
    Author
  2. name
    Tripsas CK
    type
    Author
  3. name
    Meid K
    type
    Author
  4. name
    Kanan S
    type
    Author
  5. name
    Sheehy P
    type
    Author
  6. name
    Chuma S
    type
    Author
  7. name
    Xu L
    type
    Author
  8. name
    Cao Y
    type
    Author
  9. name
    Yang G
    type
    Author
  10. name
    Liu X
    type
    Author
  11. name
    Patterson CJ
    type
    Author
  12. name
    Warren D
    type
    Author
Complete bibliographic record and source provenance
authors
  1. name
    Treon SP
    type
    Author
  2. name
    Tripsas CK
    type
    Author
  3. name
    Meid K
    type
    Author
  4. name
    Kanan S
    type
    Author
  5. name
    Sheehy P
    type
    Author
  6. name
    Chuma S
    type
    Author
  7. name
    Xu L
    type
    Author
  8. name
    Cao Y
    type
    Author
  9. name
    Yang G
    type
    Author
  10. name
    Liu X
    type
    Author
  11. name
    Patterson CJ
    type
    Author
  12. name
    Warren D
    type
    Author
bibliography ids
  1. nci-bib-40ced8d3a3ef526e5ce4b07c
book metadata
content sha256
d5795256555980af230a34a4dde4175797026e3280c9b5aaecd8ab98b56c37ac
document type
citation
dois
  1. 10.1182/blood-2014-03-566273
electronic publication date
display
2014 May 23
precision
day
year
2014
evidence scope
bibliographic_metadata_only
id
pubmed:24859363
immutable id
pubmed:24859363@d5795256555980af230a34a4dde4175797026e3280c9b5aaecd8ab98b56c37ac
journal
abbreviation
Blood
issn electronic
1528-0020
issn print
0006-4971
issue
4
name
Blood
nlm unique id
7603509
pages
503-10
volume
124
languages
  1. eng
notices
absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    Blood. 2014 Jul 24;124(4):468-9. doi: 10.1182/blood-2014-06-578625.
    note
    Source null
    related pmid
    25061164
    relationship
    Comment in
outcomes validated
false
pmid
24859363
provenance
batch id
063b6c38419f18d4021f
provider
NCBI PubMed ESummary
record sha256
b9a9e72c8fd66cea3e7fb001ccb27f8f0d4a2bf4ef6b2f7790415ac828fcc9ef
response sha256
5abcae41e9384a85f92695ef76b244ffd933f07a58a51082c160af8743d196ad
retrieved at
2026-09-09T23:47:02.607425+00:00
publication date
display
2014 Jul 24
precision
day
year
2014
publication types
  1. Clinical Trial, Phase II
  2. Journal Article
  3. Research Support, Non-U.S. Gov't
record status
PubMed - indexed for MEDLINE
schema version
1.0
source url
https://pubmed.ncbi.nlm.nih.gov/24859363/
title
Carfilzomib, rituximab, and dexamethasone (CaRD) treatment offers a neuropathy-sparing approach for treating Waldenström's macroglobulinemia.

Preserved source evidence · Independent clinical review pending · Not medical advice